相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2019)
Behcet's disease as a causative factor of cerebral venous sinus thrombosis: subgroup analysis of data from the VENOST study
Derya Uluduz et al.
RHEUMATOLOGY (2019)
Efficacy of the anti-IL 17 secukinumab in refractory Behcet's syndrome: A preliminary study
Gerardo Di Scala et al.
JOURNAL OF AUTOIMMUNITY (2019)
Behcet's disease as a cause of cerebral sinus vein thrombosis: an emerging role
Domenico Prisco et al.
RHEUMATOLOGY (2019)
Update on the treatment of Behcet's syndrome
Sinem Nihal Esatoglu et al.
INTERNAL AND EMERGENCY MEDICINE (2019)
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study
Alice Bitossi et al.
MEDIATORS OF INFLAMMATION (2019)
Long-Term Outcome of Ustekinumab Therapy for Behcet's Disease
Adrien Mirouse et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Trial of Apremilast for Oral Ulcers in Behcet's Syndrome
Guelen Hatemi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Behcet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects
M. Becatti et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
Triggering agents and microbiome as environmental factors on Behcet's syndrome
Gonca Mumcu et al.
INTERNAL AND EMERGENCY MEDICINE (2019)
Vascular Behcet's syndrome: an update
Giacomo Emmi et al.
INTERNAL AND EMERGENCY MEDICINE (2019)
Interferon alpha might be an alternative therapeutic choice for refractory Neuro-Behcet's disease
Ertugrul Cagri Bolek et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Response to correspondence: Interferon alpha might be an alternative therapeutic choice for refractory neuro-Behcet's disease - Authors reply
Frederic London et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Cognitive Functioning and Silent Neurological Manifestations in Behcet's Disease with Ocular Involvement
Yavuz Altunkaynak et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY (2019)
2018 update of the EULAR recommendations for the management of Behcet's syndrome
Gulen Hatemi et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Predictors of sustained clinical response in patients with Beh double dagger et's disease-related uveitis treated with infliximab and adalimumab
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2018)
Behcet's Syndrome and Nervous System Involvement
Ugur Uygunoglu et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
Oxidative stress and inflammation: new molecular targets for cardiovascular diseases
Matteo Becatti et al.
INTERNAL AND EMERGENCY MEDICINE (2018)
Behcet syndrome: a contemporary view (vol 14, pg 107, 2018)
Hasan Yazici et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Associated arterial and venous cerebral manifestations in Behcet's disease
C. Breniere et al.
REVUE NEUROLOGIQUE (2018)
Can anticoagulation therapy in cerebral venous thrombosis associated with Behcet's disease be stopped without relapse?
M. Roriz et al.
REVUE NEUROLOGIQUE (2018)
Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behcet's disease: multicentre retrospective study
Belen Atienza-Mateo et al.
RHEUMATOLOGY (2018)
Improvement of neurological and ocular symptoms of Beh‡et's disease after the introduction of infliximab
Marko Baresic et al.
RHEUMATOLOGY INTERNATIONAL (2018)
INTERFERON-ALPHA FOR THE MANAGEMENT OF LOWER EXTREMITY DEEP VEIN THROMBOSIS IN BEHCET'S SYNDROME: A CASE SERIES
Y. Ozguler et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Cerebral venous sinus thrombosis in Beh‡et's disease: a retrospective case-control study
Jing Shi et al.
CLINICAL RHEUMATOLOGY (2018)
Is Behcet's disease a class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behcet's disease
M. Giza et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
Cumulative retention rate of adalimumab in patients with Behcet's disease-related uveitis: a four-year follow-up study
Claudia Fabiani et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2018)
Focus on neuro-Behcet's disease: A review
Paola Caruso et al.
NEUROLOGY INDIA (2018)
Efficacy and safety of adalimumab in Beh‡et's disease-related uveitis: a multicenter retrospective observational study
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2017)
High-dose intravenous steroid pulse therapy in ocular involvement of Behcet's disease: a pilot double-blind controlled study
Mastaneh Mohammadi et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
Ustekinumab for Behcet's disease
Adrien Mirouse et al.
JOURNAL OF AUTOIMMUNITY (2017)
Cytokine Signatures in Mucocutaneous and Ocular Behcet's Disease
Giuseppe Lopalco et al.
FRONTIERS IN IMMUNOLOGY (2017)
Treatment of mucocutaneous manifestations in Behcet's disease with anakinra: a pilot open-label study
Peter C. Grayson et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behcet Disease
Matteo Becatti et al.
CIRCULATION (2016)
Efficacy and safety profile of anti-interleukin-1 treatment in Behcet's disease: a multicenter retrospective study
Giacomo Emmi et al.
CLINICAL RHEUMATOLOGY (2016)
Behcet's Disease and Nervous System Involvement
Murat Kurtuncu et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2016)
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial
Quan Dong Nguyen et al.
LANCET (2016)
Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease An Observational Study
Anne Claire Desbois et al.
MEDICINE (2016)
Adalimumab in Patients with Active Noninfectious Uveitis
Glenn J. Jaffe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Tocilizumab-induced exacerbation of mucosal ulcers in a patient with multi-refractory Behçet׳s disease
Giacomo Emmi et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
Endovascular Repair and Adjunctive Immunosuppressive Therapy of Aortic Involvement in Behcet's Disease
O. Balcioglu et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2015)
Efficacy of anti-TNF alpha in severe and/or refractory Behcet's disease: Multicenter study of 124 patients
H. Vallet et al.
JOURNAL OF AUTOIMMUNITY (2015)
Clinical and Ultrasonographic Evaluation of Lower-extremity Vein Thrombosis in Behcet Syndrome An Observational Study
Emire Seyahi et al.
MEDICINE (2015)
Behcet Disease With Vascular Involvement Effects of Different Therapeutic Regimens on the Incidence of New Relapses
Fatma Alibaz-Oner et al.
MEDICINE (2015)
Apremilast for Behcet's Syndrome - A Phase 2, Placebo-Controlled Study
Gulen Hatemi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Tocilizumab for severe refractory neuro-Behcet: Three cases IL-6 blockade in neuro-Behcet
Olga Addimanda et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Pulmonary artery involvement in Behcet's syndrome: Effects of anti-Tnf treatment
Vedat Hamuryudan et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Ocular Involvement of Behcet's Syndrome: a Comprehensive Review
Yilmaz Ozyazgan et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2015)
Anakinra treatment in drug-resistant Behcet's disease: a case series
Luca Cantarini et al.
CLINICAL RHEUMATOLOGY (2015)
Paradoxical mucocutaneous flare in a case of Beh‡et's disease treated with tocilizumab
Luca Cantarini et al.
CLINICAL RHEUMATOLOGY (2015)
The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy
Luca Cantarini et al.
CLINICAL RHEUMATOLOGY (2015)
Thrombosis in vasculitis: from pathogenesis to treatment
Giacomo Emmi et al.
THROMBOSIS JOURNAL (2015)
Unmet need in Behcet's disease: most patients in routine follow-up continue to have oral ulcers
Fatma Alibaz-Oner et al.
CLINICAL RHEUMATOLOGY (2014)
Behcet's syndrome pathophysiology and potential therapeutic targets
Giacomo Emmi et al.
INTERNAL AND EMERGENCY MEDICINE (2014)
Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10years
Fereydoun Davatchi et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2014)
Neuro-behcet's disease in South Korea: clinical characteristics and treatment response
Da-Lim Yoon et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2014)
Diagnosis and management of Neuro-Beh‡et's disease: international consensus recommendations
Seema Kalra et al.
JOURNAL OF NEUROLOGY (2014)
Neurological manifestations of Behcet's disease
N. Noel et al.
REVUE DE MEDECINE INTERNE (2014)
Vascular involvement in Behcet's syndrome: a retrospective analysis of associations and the time course
Koray Tascilar et al.
RHEUMATOLOGY (2014)
Efficacy of adalimumab therapy for life-threatening pulmonary vasculitis in Beh‡et's disease
Suhail Aamar et al.
RHEUMATOLOGY INTERNATIONAL (2014)
Long-Term Outcome of Neuro-Behcet's Disease
Nicolas Noel et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Immunosuppressants reduce venous thrombosis relapse in Behcet's disease
A. C. Desbois et al.
ARTHRITIS AND RHEUMATISM (2012)
Tocilizumab treatment for neuro-Behcet's disease, the first report
Lee S. Shapiro et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2012)
Beh‡et Syndrome: Is It One Condition?
H. Yazici et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2012)
The papulopustular lesion/arthritis cluster of Behcet's syndrome also clusters in families
Mehmet Karaca et al.
RHEUMATOLOGY (2012)
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behcet's disease refractory to standard immunosuppressive drugs
AnnaRita Giardina et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Anti-TNF Agents for Behcet's Disease: Analysis of Published Data on 369 Patients
Aikaterini Arida et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Adalimumab treatment for life threatening pulmonary artery aneurysm in Behcet disease: a case report
Sung-Won Lee et al.
CLINICAL RHEUMATOLOGY (2010)
Cerebral Venous Thrombosis in Behcet's Disease
D. Saadoun et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Colchicine versus placebo in Behcet's disease: randomized, double-blind, controlled crossover trial
Fereydoun Davatchi et al.
MODERN RHEUMATOLOGY (2009)
Increased enthesopathy among Behcet's syndrome patients with acne and arthritis
Gulen Hatemi et al.
ARTHRITIS AND RHEUMATISM (2008)
Effect of infliximab in progressive Neuro-Behcet's syndrome
Hirotoshi Kikuchi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Treatment of venous thrombosis associated with Behcet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation
Joong Kyong Ahn et al.
CLINICAL RHEUMATOLOGY (2008)
CNS involvement occurs more frequently in patients with Behcet's disease under cyclosporin A (CSA) than under other medications -: results of a retrospective analysis of 117 cases
Ina Koetter et al.
CLINICAL RHEUMATOLOGY (2006)
Cerebral venous thrombosis is associated with major vessel disease in Behcet's syndrome
R Tunc et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Endovascular therapy combined with immunosuppressive treatment for pseudoaneurysms in patients with Behcet's disease
BK Koo et al.
JOURNAL OF ENDOVASCULAR THERAPY (2003)
The long-term mortality and morbidity of Behcet syndrome - A 2-decade outcome survey of 387 patients followed at a dedicated center
E Kural-Seyahi et al.
MEDICINE (2003)
Interferon alfa-2a in the treatment of Behcet disease - A randomized placebo-controlled and double-blind study
E Alpsoy et al.
ARCHIVES OF DERMATOLOGY (2002)
Papulopustular skin lesions are seen more frequently in patients with Behcet's syndrome who have arthritis: a controlled and masked study
E Diri et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Behcet's disease:: diagnostic and prognostic aspects of neurological involvement
A Siva et al.
JOURNAL OF NEUROLOGY (2001)
分享论文
